A cohort study of duplicate faecal immunochemical testing in patients at risk of colorectal cancer from North-West England
Authors:
Open Access
Abstract
Objectives We sought to investigate if duplicate faecal immunochemical testing (FIT) sampling improves the negative and positive predictive value of patients thought to be at risk of colorectal cancer (CRC). Specifically, we aimed to investigate whether the proportion of FIT-negative CRC missed by a single FIT test in symptomatic patients could be reduced by duplicate FIT testing. Design A retrospective service evaluation cohort study of the diagnostic accuracy of duplicate FIT testing. Setting Patients referred from primary care with suspected CRC to four secondary care trusts in North-West England. Participants 28 622 patients over 18-years-old with lower gastrointestinal symptoms suggestive of CRC who completed two FIT samples. Primary and secondary outcome measures The performance of duplicate FIT for detecting CRC at a threshold of 10 µgHb/g. Results The sensitivity if either test was >10 µgHb/g was 0.978 (0.955–0.989), specificity was 0.662 (0.657–0.668), positive predictive value 0.031 (0.028–0.035) and negative predictive value 1.00 (0.999–1.00). Despite two-thirds of patients (18952) being negative following two tests, at this threshold only seven CRC were missed over a 26-month period. All seven patients had other high-risk features which should have prompted investigation. Conclusions This study suggests that in routine NHS practice, a duplicate FIT sample strategy together with clinical evaluation for evidence of anaemia and weight loss is superior to a single FIT sample alone and would allow symptomatic patients to be managed in primary care without the need for urgent referral to secondary care for urgent colonic imaging.Keywords
This publication has 27 references indexed in Scilit:
- FIT negative cancers: A right-sided problem? Implications for screening and whether iron deficiency anaemia has a role to playThe Surgeon, 2021
- Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based studyThe Lancet Gastroenterology & Hepatology, 2019
- Systematic review with meta‐analysis of over 90 000 patients. Does fast‐track review diagnose colorectal cancer earlier?Alimentary Pharmacology & Therapeutics, 2019
- High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysisWorld Journal of Gastroenterology, 2019
- Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancerScandinavian Journal of Gastroenterology, 2018
- Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer DetectionAnnals of Internal Medicine, 2018
- Endoscopy in 2017: a national survey of practice in the UKFrontline Gastroenterology, 2018
- Association Between Concentrations of Hemoglobin Determined by Fecal Immunochemical Tests and Long-term Development of Advanced Colorectal NeoplasiaGastroenterology, 2017
- Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysisGut, 2008
- Rates of New or Missed Colorectal Cancers After Colonoscopy and Their Risk Factors: A Population-Based AnalysisGastroenterology, 2007